S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
NASDAQ:OPK

OPKO Health Stock Forecast, Price & News

$3.72
-0.04 (-1.06 %)
(As of 10/15/2021 04:00 PM ET)
Add
Compare
Today's Range
$3.71
$3.79
50-Day Range
$3.45
$3.94
52-Week Range
$3.02
$6.27
Volume2.02 million shs
Average Volume5.11 million shs
Market Capitalization$2.53 billion
P/E Ratio33.82
Dividend YieldN/A
Beta1.75
30 days | 90 days | 365 days | Advanced Chart
Receive OPK News and Ratings via Email

Sign-up to receive the latest news and ratings for OPKO Health and its competitors with MarketBeat's FREE daily newsletter.


OPKO Health logo

About OPKO Health

OPKO Health, Inc., is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:OPK
CUSIP
68375N10
Employees
5,269
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.44 billion
Cash Flow
$0.18 per share
Book Value
$2.49 per share

Profitability

Net Income
$30.59 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$2.53 billion
Next Earnings Date
11/4/2021 (Estimated)
Optionable
Optionable

MarketRank

Overall MarketRank

2.27 out of 5 stars

Medical Sector

294th out of 1,361 stocks

Pharmaceutical Preparations Industry

134th out of 668 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.0 5 -4 -3 -2 -1 -












OPKO Health (NASDAQ:OPK) Frequently Asked Questions

Is OPKO Health a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OPKO Health in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" OPKO Health stock.
View analyst ratings for OPKO Health
or view top-rated stocks.

What stocks does MarketBeat like better than OPKO Health?

Wall Street analysts have given OPKO Health a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but OPKO Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is OPKO Health's next earnings date?

OPKO Health is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for OPKO Health
.

How were OPKO Health's earnings last quarter?

OPKO Health, Inc. (NASDAQ:OPK) announced its quarterly earnings results on Thursday, July, 29th. The biotechnology company reported ($0.03) earnings per share for the quarter, missing the Zacks' consensus estimate of $0.02 by $0.05. The biotechnology company had revenue of $442.40 million for the quarter, compared to analyst estimates of $457.57 million. OPKO Health had a trailing twelve-month return on equity of 4.21% and a net margin of 3.71%.
View OPKO Health's earnings history
.

How has OPKO Health's stock been impacted by Coronavirus (COVID-19)?

OPKO Health's stock was trading at $1.69 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OPK stock has increased by 120.1% and is now trading at $3.72.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for OPK?

3 equities research analysts have issued 12 month price objectives for OPKO Health's shares. Their forecasts range from $5.00 to $7.00. On average, they anticipate OPKO Health's stock price to reach $6.00 in the next year. This suggests a possible upside of 61.3% from the stock's current price.
View analysts' price targets for OPKO Health
or view top-rated stocks among Wall Street analysts.

Who are OPKO Health's key executives?

OPKO Health's management team includes the following people:
  • Phillip Frost, Chairman & Chief Executive Officer
  • Jon Roger Cohen, Director & Senior Vice President
  • Adam E. Logal, CFO, Treasurer, Chief Accounting Officer & SVP
  • Jane H. Hsaio, Vice Chairman & Chief Technical Officer
  • Steven D. Rubin, Director & Executive Vice President-Administration

What is Philip Frost's approval rating as OPKO Health's CEO?

21 employees have rated OPKO Health CEO Philip Frost on Glassdoor.com. Philip Frost has an approval rating of 16% among OPKO Health's employees. This puts Philip Frost in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OPKO Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OPKO Health investors own include TherapeuticsMD (TXMD), Micron Technology (MU), NVIDIA (NVDA), bluebird bio (BLUE), Gilead Sciences (GILD), Pfizer (PFE), Inovio Pharmaceuticals (INO), Novavax (NVAX), Advanced Micro Devices (AMD) and AT&T (T).

What is OPKO Health's stock symbol?

OPKO Health trades on the NASDAQ under the ticker symbol "OPK."

How do I buy shares of OPKO Health?

Shares of OPK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OPKO Health's stock price today?

One share of OPK stock can currently be purchased for approximately $3.72.

How much money does OPKO Health make?

OPKO Health has a market capitalization of $2.53 billion and generates $1.44 billion in revenue each year. The biotechnology company earns $30.59 million in net income (profit) each year or $0.05 on an earnings per share basis.

How many employees does OPKO Health have?

OPKO Health employs 5,269 workers across the globe.

What is OPKO Health's official website?

The official website for OPKO Health is www.opko.com.

Where are OPKO Health's headquarters?

OPKO Health is headquartered at 4400 BISCAYNE BLVD., MIAMI FL, 33137.

How can I contact OPKO Health?

OPKO Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The biotechnology company can be reached via phone at (305) 575-4100 or via email at [email protected].


This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.